title: Telmisartan in high-risk cardiovascular patients. No need to change standard practice.
abstract: No more effective than ramipril in a trial including 25620 patients; two unconvincing placebo-controlled trials in a total of about 26 200 patients.
mesh_terms: D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use*; D001562:Benzimidazoles / Q000627:therapeutic use*; D001565:Benzoates / Q000627:therapeutic use*; D002318:Cardiovascular Diseases / Q000188:drug therapy* / Q000503:physiopathology; D002986:Clinical Trials as Topic; D006801:Humans; D017257:Ramipril / Q000627:therapeutic use; D012307:Risk Factors; D000077333:Telmisartan
chemical_list: D000806:Angiotensin-Converting Enzyme Inhibitors; D001562:Benzimidazoles; D001565:Benzoates; D017257:Ramipril; D000077333:Telmisartan